Home The Wall Street Journal: Actavis set for $20 billion corporate-bond sale
 

Keywords :   


The Wall Street Journal: Actavis set for $20 billion corporate-bond sale

2015-03-02 14:28:45| Biotech - Topix.net

Pharmaceutical company Actavis PLC is expected to sell more than $20 billion in bonds as early as this week, a deal that would rank as the second-largest corporate bond ever and further propel bond sales this year into record territory. Traders expect the bonds to fly off the shelves, with investors globally searching for income-generating investments at a time of low rates on safe government debt.

Tags: set sale street journal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.11PM responds to Sir Alan Bates after repeated requests
05.11American Angus elects 2024-25 board leaders
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Public Advisory Number 8A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Brazil gives green light to medicinal use of Cannabis in animals
More »